• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Epidemiology: Autism Spectrum Disorders Product Image

Epidemiology: Autism Spectrum Disorders

  • Published: February 2011
  • 42 pages
  • Datamonitor

The prevalence of autism spectrum disorders has dramatically increased over the last few decades to the current prevalence of approximately 1%. It is most likely that the increase in autism spectrum disorders is a result of changes in diagnostic criteria that have expanded the range of the disorder spectrum and greater overall disorder awareness in populations.

Scope of the report:

- Gain insight to market potential, including a robust 10-year epidemiology forecast of autism spectrum disorder prevalent cases.
- Understand the key epidemiologic risk factors associated with autism spectrum disorders.

Highlights:

- It is estimated that, during 2011, 6,594,000 prevalent cases of autism spectrum disorders will exist in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The largest number of cases will be in the US (2,613,000), with Japan having the next largest number of cases (1,411,000).

- Between 2011 and 2021, the number of autism spectrum disorder prevalent cases in the seven major markets is expected to increase slightly by 3.4%. This weak rising trend is attributable to overall population growth across these markets.

- READ MORE >

Executive Summary
Disease burden overview
Forecast results (2011–21)
Autism spectrum disorder subtype distributions for
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Definition of autism spectrum disorders
GLOBAL VARIATION AND HISTORICAL TRENDS
Prevalence varies over time across the seven major markets, but very little by geography
CO-MORBIDITIES
Autism spectrum disorder cases often also suffer from mental retardation, epilepsy, and other co-morbidities
RISK FACTORS
Genetics
Genetic mutations
Twin studies
Maternal and paternal age
Male sex
Environmental toxins
EPIDEMIOLOGIC FORECASTING OF AUTISM SPECTRUM DISORDERS
Sources of epidemiologic data
Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network
Prevalence of autism in a US metropolitan area
No effect of MMR withdrawal on the incidence of autism: a total population study
Population denominators
Description of prevalence forecasting methods
US
Japan
France
Germany
Italy
Spain
UK
Age
Sex
Autism spectrum disorder type
US and five major EU markets
Japan
EPIDEMIOLOGIC RESULTS
Estimated prevalent cases of autism spectrum disorders and future trends
Segmentation of prevalent cases
DISCUSSION
Strengths and limitations
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Module methodology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos